A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Condition(s):Lymphoma, Non-Hodgkin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Follicular; Lymphoma, B-CellLast Updated:March 13, 2024Recruiting